Community pharmacist assessment of 10-year risk of coronary heart disease for union workers and their dependents

Journal of the American Pharmacists Association

Volumn 48, Issue 4, 2008, Pages 515-517

  Liu, Yifei ^a   Mentele, Leslie J ^b   McDonough, Randal P ^c   Carruthers, Kara M ^d   Doucette, William R ^e  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b Walgreens   (United States)

^c Towncrest Pharmacy   (United States)

^d Main at Locust Pharmacy Clinic and Medical Supply   (United States)

^e UNIVERSITY OF IOWA   (United States)

Author keywords

Acute coronary syndromes; Community pharmacists; Risk assessment; Unions (labor)

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ARTICLE; BLOOD; BLOOD PRESSURE; CORONARY ARTERY DISEASE; FEMALE; HUMAN; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PATIENT EDUCATION; PHARMACIST; PHARMACY; PRACTICE GUIDELINE; PROFESSIONAL STANDARD; RISK FACTOR; TRADE UNION;

AGED; BLOOD PRESSURE; CHOLESTEROL; CHOLESTEROL, HDL; COMMUNITY PHARMACY SERVICES; CORONARY DISEASE; FEMALE; HUMANS; LABOR UNIONS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PHARMACISTS; PRACTICE GUIDELINES AS TOPIC; PROFESSIONAL ROLE; RISK FACTORS;

EID: 53049088327     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2008.07099     Document Type: Article

References (12)

1. American Heart Association. Heart disease and stroke statistics: 2007 update. Dallas, TX: American Heart Association; 2007.
2. Centers for Disease Control and Prevention. Preventing heart disease and stroke: addressing the nation's leading killers: at a glance 2005. Accessed at www.cdc.gov/nccdphp/publications/aag/cvh.htm, November 12, 2005.
3. Fullerton HN, Tossi M. Labor force projections to 2010: steady growth and changing composition. In: Monthly Labor Review. Washington, DC: U.S. Department of Labor, Bureau of Labor Statistics; November 2001.
4. Tossi M. Labor force projections to 2012: the graying of the U.S. workforce. In: Monthly Labor Review, Washington, DC: U.S. Department of Labor, Bureau of Labor Statistics; February 2004.
5. Sheridan S, Pignone M, Mulrow C. Framingham-based tools to calculate the global risk of coronary heart disease: a systematic review of tools for clinicians. J Gen Intern Med. 2003;18:1039-52.
6. National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health. Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) executive summary. Bethesda, MD: National Institutes of Health; 2001 (NIH publ. no. 01-3670).
7. Blenkinsopp A, Anderson C, Armstrong M. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. J Public Health Med. 2003;25:144-53.
8. Snella KA, Canales AE, Irons BK, et al. Pharmacy- and community-based screenings for diabetes and cardiovascular conditions in high risk individuals. J Am Pharm Assoc. 2006;46:370-7.
9. Ford ES, Giles WH, Mokdad AH. The distribution of 10-year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey III. J Am Coll Cardiol. 2004;43:1791-6.
10. Ajani UA, Ford ES. Has the risk for coronary heart disease changed among U.S. adults? J Am Coll Cardiol. 2006;48:1177-82.
11. Centers for Disease Control and Prevention. Preventing heart disease and stroke. Accessed at www.cdc.gov/nccdphp/publications/factsheets/Prevention/cvh. htm, November 22, 2005.
12. Wilson JB, Osterhaus MC, Farris KB, et al. Financial analysis of cardiovascular wellness program provided to self-insured company from pharmaceutical care provider's perspective. J Am Pharm Assoc. 2006;45:588-92.